About Pace Pharmaceuticals
Pace Pharmaceuticals is a private company based in Cupertino, California, incorporated in 2024 in Delaware. It has reported $50,000 raised in one offering on Form D since September 2026. Its chief executive is Douglas Yao.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Sep 28, 2026 | $50,000target not set | 1 | $50,000 | Simple Agreement for Future EquityRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pace Pharmaceuticals's Form D filed Sep 28, 2026.
DY
Douglas Yao
Chief Executive Officer and director